کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4172751 | 1275773 | 2008 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Advances in the management of primary immunodeficiency
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
Adenovirus - آدنوویروسIntravenous immunoglobulins - ایمونوگلوبولین های داخل وریدیpreventive therapy - درمان پیشگیرانهAntifungal agents - عوامل ضد قارچAntiviral agents - عوامل ضد ویروسیHuman herpesvirus - ویروس انسانی انسانیhaematopoietic stem cell transplantation - پیوند سلول های بنیادی خونریزیprimary immunodeficiency - کمبود ایمنی اولیه
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
پریناتولوژی (پزشکی مادر و جنین)، طب اطفال و بهداشت کودک
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Advances in the management of primary immunodeficiency Advances in the management of primary immunodeficiency](/preview/png/4172751.png)
چکیده انگلیسی
Primary immunodeficiency disorders (PIDs) are a heterogeneous group of diseases often presenting in childhood. Over 150 disease phenotypes due to 120 gene defects are now recognised. Their hallmark is a propensity to unusual infections but other manifestations include autoimmune phenomena, malignancy and non-immunologic features. Recognition and understanding of PIDs continue to grow rapidly and major advances have been made in both supportive and curative therapies for PID. The cornerstones of management remain antimicrobial treatment (including prophylaxis), immunoglobulin (IG) replacement and stem cell corrective therapies. Effective treatment needs an individualised approach taking into account the natural history of the patient's underlying diagnosis, their personal infection history and current status. These considerations, and the rarity of individual PID diagnoses, have meant that few randomised controlled trials have been conducted in this field. However, it is clear that persons with PID are living much longer and healthier lives, due to better tests for early diagnosis of infection, new anti-infective agents, better Ig replacement regimens and improved outcome after haematopoietic stem cell transplantation.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Paediatrics and Child Health - Volume 18, Issue 11, November 2008, Pages 502-507
Journal: Paediatrics and Child Health - Volume 18, Issue 11, November 2008, Pages 502-507
نویسندگان
Sophie Hambleton, Andrew J. Cant,